中华老年医学杂志
中華老年醫學雜誌
중화노년의학잡지
Chinese Journal of Geriatrics
2015年
2期
133-137
,共5页
王佳%王明晓%王春玲%张剑梅%石宁%平小佳%刘艳琳%屈正
王佳%王明曉%王春玲%張劍梅%石寧%平小佳%劉豔琳%屈正
왕가%왕명효%왕춘령%장검매%석저%평소가%류염림%굴정
人脉粥样硬化%蛋白酶体内肽酶复合物
人脈粥樣硬化%蛋白酶體內肽酶複閤物
인맥죽양경화%단백매체내태매복합물
Atherosclerosis%Proteasome endopeptidase comples
目的 研究蛋白酶体核心亚基在人动脉粥样硬化斑块中的表达水平,探讨蛋白酶体组成及功能与动脉粥样斑块病变间的关系. 方法 搜集颈动脉狭窄并行颈动脉内膜切除术患者病例组和主动脉夹层并行主动脉置换术患者对照组的相关临床资料.选择病例组中5例术中所切除的颈动脉粥样硬化斑块和斑块旁内膜组织,对照组中5例术中所切除的相对正常的锁骨下动脉和无名动脉组织,采用免疫印迹(Western)法检测并比较其中的蛋白酶体核心亚基的蛋白质水平. 结果 病例组高脂血症、糖尿病及吸烟比率与对照组比较差异无统计学意义(x2值分别为0.61、1.67、1.67,均 P>0.05);与对照组比较,β类亚基中组成型亚基β3、β4(F值分别为56.576、27.846,均P<0.05)以及催化亚基β1和β5在斑块核心部分的表达水平下调(F值分别为8.221、82.716,均P<0.05),而免疫亚基β1i和β5i的表达水平升高(F值分别为50.167、229.743,均P<0.05). 结论 免疫蛋白酶体特征性催化亚基β1i和β5i在粥样斑块核心组织中表达上调,提示由组成型蛋白酶体(β1和β5为其特征性催化亚基)向免疫蛋白酶体转变这一动态过程与动脉粥样硬化斑块形成过程密切相关.
目的 研究蛋白酶體覈心亞基在人動脈粥樣硬化斑塊中的錶達水平,探討蛋白酶體組成及功能與動脈粥樣斑塊病變間的關繫. 方法 搜集頸動脈狹窄併行頸動脈內膜切除術患者病例組和主動脈夾層併行主動脈置換術患者對照組的相關臨床資料.選擇病例組中5例術中所切除的頸動脈粥樣硬化斑塊和斑塊徬內膜組織,對照組中5例術中所切除的相對正常的鎖骨下動脈和無名動脈組織,採用免疫印跡(Western)法檢測併比較其中的蛋白酶體覈心亞基的蛋白質水平. 結果 病例組高脂血癥、糖尿病及吸煙比率與對照組比較差異無統計學意義(x2值分彆為0.61、1.67、1.67,均 P>0.05);與對照組比較,β類亞基中組成型亞基β3、β4(F值分彆為56.576、27.846,均P<0.05)以及催化亞基β1和β5在斑塊覈心部分的錶達水平下調(F值分彆為8.221、82.716,均P<0.05),而免疫亞基β1i和β5i的錶達水平升高(F值分彆為50.167、229.743,均P<0.05). 結論 免疫蛋白酶體特徵性催化亞基β1i和β5i在粥樣斑塊覈心組織中錶達上調,提示由組成型蛋白酶體(β1和β5為其特徵性催化亞基)嚮免疫蛋白酶體轉變這一動態過程與動脈粥樣硬化斑塊形成過程密切相關.
목적 연구단백매체핵심아기재인동맥죽양경화반괴중적표체수평,탐토단백매체조성급공능여동맥죽양반괴병변간적관계. 방법 수집경동맥협착병행경동맥내막절제술환자병례조화주동맥협층병행주동맥치환술환자대조조적상관림상자료.선택병례조중5례술중소절제적경동맥죽양경화반괴화반괴방내막조직,대조조중5례술중소절제적상대정상적쇄골하동맥화무명동맥조직,채용면역인적(Western)법검측병비교기중적단백매체핵심아기적단백질수평. 결과 병례조고지혈증、당뇨병급흡연비솔여대조조비교차이무통계학의의(x2치분별위0.61、1.67、1.67,균 P>0.05);여대조조비교,β류아기중조성형아기β3、β4(F치분별위56.576、27.846,균P<0.05)이급최화아기β1화β5재반괴핵심부분적표체수평하조(F치분별위8.221、82.716,균P<0.05),이면역아기β1i화β5i적표체수평승고(F치분별위50.167、229.743,균P<0.05). 결론 면역단백매체특정성최화아기β1i화β5i재죽양반괴핵심조직중표체상조,제시유조성형단백매체(β1화β5위기특정성최화아기)향면역단백매체전변저일동태과정여동맥죽양경화반괴형성과정밀절상관.
Objective To explore the relationship of atherosclerotic plaques with the component and function of proteasome complex by systematically investigating the protein levels of proteasome core subunits in human atherosclerotic plaques.Methods Clinical data of the observation group (patients with carotid artery stenosis undergoing carotid artery endarterectomy) and control group (patients with aortic dissection who underwent aortic replacement) were collected.The carotid endarterectomy specimens including the carotid atherosclerosis plaques and endometrial tissues adjacent to plaques were removed from 5 patients in observation group,and the relatively normal arterial intima(subclavian artery and innominate artery) were taken from 5 patients in control group.The protein levels of the proteasome subunits were measured by Western blotting.Results There was no significant difference in the occurrences of diabetes,hyperlipidemia and smoking between the two groups (x2 =0.61,1.67 and 1.67,all P> 0.05).Compared with the control group,the observation group showed that the levels of two non-catalytic β subunits β3 and β4 (F=56.576 and 27.846,both P<0.05),and the catalytic subunits β1 and β5 (F=8.221 and 82.716,both P<0.05) were significantly down-regulated in the plaques,whereas the expressions of β1i and β5i in the plaques (F=50.167、229.743,P<0.05) were robustly elevated.Conclusions The levels of the catalytic subunits of immune proteasome β1i and β5i are up-regulated in the atherosclerotic plaques,which indicates that the transformation from the constitutive proteasomes (β1 and β5) to the immune-proteasomes (β1i and β5i) is highly involved in the atherosclerosis.